Usefulness of Functional Thyroid-Stimulating and Thyroid-Blocking Immunoglobulin Bioassays in an Atypical Presentation of Graves’ Disease

BACKGROUND/OBJECTIVE: Thyroid-stimulating hormone (TSH) receptor antibody (TRAb) is well recognized as the pathogenic antibody that causes the clinical manifestation of Graves’ disease (GD). Although the majority of TRAb measured in GD is due to thyroid-stimulating immunoglobulin (TSI), there are ot...

Descripción completa

Detalles Bibliográficos
Autores principales: Sherfan, Julie, Samad, Navira, Hsieh, Albert, Sullivan, David, Fuller, Peter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association of Clinical Endocrinology 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213846/
https://www.ncbi.nlm.nih.gov/pubmed/37251977
http://dx.doi.org/10.1016/j.aace.2023.02.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213846/
https://www.ncbi.nlm.nih.gov/pubmed/37251977
http://dx.doi.org/10.1016/j.aace.2023.02.004

Ejemplares similares